Literature DB >> 29167217

5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.

Gyanendra Acharya1, Maria T Cruz Carreras1, Terry Wynne Rice2.   

Abstract

5-Fluorouracil (5-FU), a commonly used antimetabolite and antineoplastic agent, has been approved for treatment of various cancers. Neurotoxicities are considered extremely rare side effects of 5-FU. We present a case of 5-FU-induced encephalopathy with diffusion-restricted reversible lesion of the splenium of the corpus callosum in a patient with colorectal cancer. The patient presented with confusion, dysarthria and agitation after 5-FU infusion. The prognosis of this toxic effects of 5-FU is usually good if recognised and treated in time. Emergency physicians, general practitioners and oncologists should be aware of this rare side effects of 5-FU chemotherapy and its diagnosis and treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  chemotherapy; colon cancer; delirium; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2017        PMID: 29167217      PMCID: PMC5720253          DOI: 10.1136/bcr-2017-222030

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI.

Authors:  Reiko Akitake; Shin'ichi Miyamoto; Fumiyasu Nakamura; Takahiro Horimatsu; Yasumasa Ezoe; Manabu Muto; Tsutomu Chiba
Journal:  Jpn J Clin Oncol       Date:  2010-10-06       Impact factor: 3.019

2.  Atypical diffusion-restricted lesion in 5-Fluorouracil encephalopathy.

Authors:  W-W Lee; J-S Kim; K R Son; H-M Kwon
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

Review 3.  Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action.

Authors:  Peter V Danenberg; Bengt Gustavsson; Patrick Johnston; Per Lindberg; Rudolf Moser; Elisabeth Odin; Godefridus J Peters; Nicholas Petrelli
Journal:  Crit Rev Oncol Hematol       Date:  2016-08-09       Impact factor: 6.312

Review 4.  Severe hyperammonaemia in adults not explained by liver disease.

Authors:  Valerie Walker
Journal:  Ann Clin Biochem       Date:  2012-02-20       Impact factor: 2.057

5.  Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.

Authors:  L T Lucato; A M McKinney; J Short; M Teksam; C L Truwit
Journal:  Australas Radiol       Date:  2006-08

6.  High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

Authors:  K H Yeh; A L Cheng
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation fulfilling criteria for recombinant tissue plasminogen activator therapy.

Authors:  Ryuta Kinno; Yoshitaka Kii; Masanobu Uchiyama; Yoshiyuki Owan; Takahiro Yamazaki; Toshiya Fukui
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-02-17       Impact factor: 2.136

8.  UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.

Authors:  Kimie Sai; Mayumi Saeki; Yoshiro Saito; Shogo Ozawa; Noriko Katori; Hideto Jinno; Ryuichi Hasegawa; Nahoko Kaniwa; Jun-ichi Sawada; Kazuo Komamura; Kazuyuki Ueno; Shiro Kamakura; Masafumi Kitakaze; Yutaka Kitamura; Naoyuki Kamatani; Hironobu Minami; Atsushi Ohtsu; Kuniaki Shirao; Teruhiko Yoshida; Nagahiro Saijo
Journal:  Clin Pharmacol Ther       Date:  2004-06       Impact factor: 6.875

9.  Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

10.  Fatal Nonhepatic Hyperammonemia in ICU Setting: A Rare but Serious Complication following Bariatric Surgery.

Authors:  Gyanendra Acharya; Sunil Mehra; Ronakkumar Patel; Simona Frunza-Stefan; Harmanjot Kaur
Journal:  Case Rep Crit Care       Date:  2016-04-10
View more
  2 in total

1.  5-Fluorouracil Neurotoxicity in the Absence of Dihydropyrimidine Dehydrogenase Deficiency Case Report.

Authors:  Rebecca Jules; Arushi Thaper; Ryan Foster; Pouya Ameli; Christopher Robinson; Michael Pizzi; Marc-Alain Babi; Carolina B Maciel; Katharina M Busl; Raju Reddy; William Roth
Journal:  Neurohospitalist       Date:  2022-01-03

Review 2.  The splenium of the corpus callosum: embryology, anatomy, function and imaging with pathophysiological hypothesis.

Authors:  J Blaauw; L C Meiners
Journal:  Neuroradiology       Date:  2020-02-15       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.